Volume | 1,138 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
ADC Therapeutics SA | ADCT | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.20 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
16 | 1,138 | - | 0.359908 - 6.04 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
07:35:28 | 20 | $ 4.30 | USD |
ADC Therapeutics SA Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
346.62M | 82.53M | - | 209.91M | -155.8M | -1.89 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ADC Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADCT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.82 | 4.84 | 4.07 | 4.36 | 249,671 | -0.44 | -9.13% |
1 Month | 4.55 | 5.38 | 3.23 | 4.44 | 559,277 | -0.17 | -3.74% |
3 Months | 1.54 | 6.04 | 1.4501 | 3.64 | 819,633 | 2.84 | 184.42% |
6 Months | 0.8531 | 6.04 | 0.359908 | 2.60 | 666,092 | 3.53 | 413.42% |
1 Year | 2.00 | 6.04 | 0.359908 | 2.27 | 570,326 | 2.38 | 119.00% |
3 Years | 25.55 | 32.00 | 0.359908 | 7.05 | 419,149 | -21.17 | -82.86% |
5 Years | 30.00 | 56.5899 | 0.359908 | 11.06 | 381,028 | -25.62 | -85.40% |
ADC Therapeutics Description
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. |